• پذیرش: شنبه تا چهارشنبه، ساعت 17 تا 19:30
  • تلفن تماس: 35567979-041
  • آدرس مطب: تبریز، خیابان 17 شهریور جدید، جنب آزمایشگاه مهر، طبقه اول

vulvovaginal atrophy

OBJECTIVE:

METHODS:

RESULTS:

CONCLUSION:

KEYWORDS:

PubMed Commons home

Maturitas. 2015 Mar;80(3):296301.

doi: 10.1016/j.maturitas.2014.12.006. Epub 2014 Dec 25.

Vulvovaginal

atrophy: a new treatment modality using thermoablative

fractional CO2 laser.

Perino A , Calligaro A , Forlani F , Tiberio C , Cucinella G , Svelato A , Saitta S , Calagna G .

Abstract

To evaluate the efficacy and feasibility of thermoablative

fractional CO2 laser for

the treatment of symptoms related to vulvovaginal

atrophy (VVA) in postmenopausal

women.

From April 2013 to December 2013, postmenopausal

patients who complained of

one or more VVArelated

symptoms and who underwent vaginal treatment with fractional CO2

laser were enrolled in the study. At baseline (T0) and 30 days posttreatment

(T1), vaginal status

of the women was evaluated using the Vaginal Health Index (VHI), and subjective intensity of

VVA symptoms was evaluated using a visual analog scale (VAS). At T1, treatment satisfaction

was evaluated using a 5point

Likert scale.

During the study period, a total of 48 patients were enrolled. Data indicated a

significant improvement in VVA symptoms (vaginal dryness, burning, itching and dyspareunia)

(P<0.0001) in patients who had undergone 3 sessions of vaginal fractional CO2 laser treatment.

Moreover, VHI scores were significantly higher at T1 (P<0.0001). Overall, 91.7% of patients were

satisfied or very satisfied with the procedure and experienced considerable improvement in

quality of life (QoL). No adverse events due to fractional CO2 laser treatment occurred.

Thermoablative

fractional CO2 laser could be a safe, effective and feasible

option for the treatment of VVA symptoms in postmenopausal

women.

Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Laser treatment; Menopause; Vulvovaginal

atrophy

PMID: 25596815 [PubMed in

process]

PubMed Commons

0 comments

Abstract

1 2 3 1 1 1 4 1

Author information